Patient Reported Outcomes in Renal Transplant Patients With and Without Gastrointestinal Symptoms.
Phase of Trial: Phase IV
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Mycophenolate sodium (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions
- Sponsors Novartis
- 01 Nov 2011 Actual end date (Jun 2007) added as reported by ClinicalTrials.gov.
- 01 Oct 2007 Status change
- 27 Sep 2007 New trial record.